Financhill
Sell
40

EHAB Quote, Financials, Valuation and Earnings

Last price:
$9.22
Seasonality move :
4.31%
Day range:
$9.20 - $9.35
52-week range:
$6.47 - $10.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.45x
P/B ratio:
0.82x
Volume:
501.6K
Avg. volume:
476K
1-year change:
18.05%
Market cap:
$466.6M
Revenue:
$1B
EPS (TTM):
-$0.25

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
EHAB
Enhabit, Inc.
$270.8M $0.16 4.87% 523.7% $9.75
AIRS
AirSculpt Technologies, Inc.
$34.9M -$0.03 -10.84% -65.36% $6.00
CVS
CVS Health Corp.
$103.8B $0.99 6.44% -24.01% $94.33
IQV
IQVIA Holdings, Inc.
$4.2B $3.40 7.15% 40.55% $253.95
JYNT
The Joint Corp. (United States)
$14.1M $0.04 -4.06% 3233.33% $10.67
WORX
SCWorx Corp.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
EHAB
Enhabit, Inc.
$9.22 $9.75 $466.6M -- $0.00 0% 0.45x
AIRS
AirSculpt Technologies, Inc.
$1.98 $6.00 $123.6M 300.71x $0.00 0% 0.75x
CVS
CVS Health Corp.
$79.36 $94.33 $100.7B 207.42x $0.67 3.35% 0.26x
IQV
IQVIA Holdings, Inc.
$225.41 $253.95 $38.4B 30.95x $0.00 0% 2.49x
JYNT
The Joint Corp. (United States)
$8.72 $10.67 $129.6M 75.63x $0.00 0% 2.44x
WORX
SCWorx Corp.
$0.19 -- $2.9M -- $0.00 0% 0.27x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
EHAB
Enhabit, Inc.
47.68% 0.835 118.52% 1.53x
AIRS
AirSculpt Technologies, Inc.
51.18% 10.356 17.19% 0.22x
CVS
CVS Health Corp.
52.85% -0.062 85.22% 0.49x
IQV
IQVIA Holdings, Inc.
71.15% 1.035 46.77% 0.62x
JYNT
The Joint Corp. (United States)
8.44% -0.249 1.44% 1.02x
WORX
SCWorx Corp.
0.05% 2.097 0.08% 1.15x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
EHAB
Enhabit, Inc.
$122.3M $16.8M -0.89% -1.74% 6.37% $36.2M
AIRS
AirSculpt Technologies, Inc.
$16.9M -$1.3M -10.01% -21.8% -3.72% -$405K
CVS
CVS Health Corp.
$13.8B $3B 0.27% 0.57% 2.88% $98M
IQV
IQVIA Holdings, Inc.
$1.1B $572M 6.13% 20.65% 13.96% $772M
JYNT
The Joint Corp. (United States)
$10.3M $516K -1.2% -1.38% 3.86% $1.5M
WORX
SCWorx Corp.
$119.1K -$138.9K -74.13% -74.77% -19.68% -$358.1K

Enhabit, Inc. vs. Competitors

  • Which has Higher Returns EHAB or AIRS?

    AirSculpt Technologies, Inc. has a net margin of 4.4% compared to Enhabit, Inc.'s net margin of -27.18%. Enhabit, Inc.'s return on equity of -1.74% beat AirSculpt Technologies, Inc.'s return on equity of -21.8%.

    Company Gross Margin Earnings Per Share Invested Capital
    EHAB
    Enhabit, Inc.
    46.4% $0.22 $1.1B
    AIRS
    AirSculpt Technologies, Inc.
    48.33% -$0.15 $168.2M
  • What do Analysts Say About EHAB or AIRS?

    Enhabit, Inc. has a consensus price target of $9.75, signalling upside risk potential of 5.75%. On the other hand AirSculpt Technologies, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 203.03%. Given that AirSculpt Technologies, Inc. has higher upside potential than Enhabit, Inc., analysts believe AirSculpt Technologies, Inc. is more attractive than Enhabit, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    EHAB
    Enhabit, Inc.
    1 4 0
    AIRS
    AirSculpt Technologies, Inc.
    0 2 0
  • Is EHAB or AIRS More Risky?

    Enhabit, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison AirSculpt Technologies, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock EHAB or AIRS?

    Enhabit, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AirSculpt Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enhabit, Inc. pays -- of its earnings as a dividend. AirSculpt Technologies, Inc. pays out 3.05% of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios EHAB or AIRS?

    Enhabit, Inc. quarterly revenues are $263.6M, which are larger than AirSculpt Technologies, Inc. quarterly revenues of $35M. Enhabit, Inc.'s net income of $11.6M is higher than AirSculpt Technologies, Inc.'s net income of -$9.5M. Notably, Enhabit, Inc.'s price-to-earnings ratio is -- while AirSculpt Technologies, Inc.'s PE ratio is 300.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enhabit, Inc. is 0.45x versus 0.75x for AirSculpt Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    EHAB
    Enhabit, Inc.
    0.45x -- $263.6M $11.6M
    AIRS
    AirSculpt Technologies, Inc.
    0.75x 300.71x $35M -$9.5M
  • Which has Higher Returns EHAB or CVS?

    CVS Health Corp. has a net margin of 4.4% compared to Enhabit, Inc.'s net margin of -3.88%. Enhabit, Inc.'s return on equity of -1.74% beat CVS Health Corp.'s return on equity of 0.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    EHAB
    Enhabit, Inc.
    46.4% $0.22 $1.1B
    CVS
    CVS Health Corp.
    13.43% -$3.13 $154.9B
  • What do Analysts Say About EHAB or CVS?

    Enhabit, Inc. has a consensus price target of $9.75, signalling upside risk potential of 5.75%. On the other hand CVS Health Corp. has an analysts' consensus of $94.33 which suggests that it could grow by 19.2%. Given that CVS Health Corp. has higher upside potential than Enhabit, Inc., analysts believe CVS Health Corp. is more attractive than Enhabit, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    EHAB
    Enhabit, Inc.
    1 4 0
    CVS
    CVS Health Corp.
    17 4 0
  • Is EHAB or CVS More Risky?

    Enhabit, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.486, suggesting its less volatile than the S&P 500 by 51.445%.

  • Which is a Better Dividend Stock EHAB or CVS?

    Enhabit, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.35% to investors and pays a quarterly dividend of $0.67 per share. Enhabit, Inc. pays -- of its earnings as a dividend. CVS Health Corp. pays out 72.76% of its earnings as a dividend. CVS Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios EHAB or CVS?

    Enhabit, Inc. quarterly revenues are $263.6M, which are smaller than CVS Health Corp. quarterly revenues of $102.9B. Enhabit, Inc.'s net income of $11.6M is higher than CVS Health Corp.'s net income of -$4B. Notably, Enhabit, Inc.'s price-to-earnings ratio is -- while CVS Health Corp.'s PE ratio is 207.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enhabit, Inc. is 0.45x versus 0.26x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    EHAB
    Enhabit, Inc.
    0.45x -- $263.6M $11.6M
    CVS
    CVS Health Corp.
    0.26x 207.42x $102.9B -$4B
  • Which has Higher Returns EHAB or IQV?

    IQVIA Holdings, Inc. has a net margin of 4.4% compared to Enhabit, Inc.'s net margin of 8.1%. Enhabit, Inc.'s return on equity of -1.74% beat IQVIA Holdings, Inc.'s return on equity of 20.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    EHAB
    Enhabit, Inc.
    46.4% $0.22 $1.1B
    IQV
    IQVIA Holdings, Inc.
    26.49% $1.93 $21.5B
  • What do Analysts Say About EHAB or IQV?

    Enhabit, Inc. has a consensus price target of $9.75, signalling upside risk potential of 5.75%. On the other hand IQVIA Holdings, Inc. has an analysts' consensus of $253.95 which suggests that it could grow by 12.66%. Given that IQVIA Holdings, Inc. has higher upside potential than Enhabit, Inc., analysts believe IQVIA Holdings, Inc. is more attractive than Enhabit, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    EHAB
    Enhabit, Inc.
    1 4 0
    IQV
    IQVIA Holdings, Inc.
    16 5 0
  • Is EHAB or IQV More Risky?

    Enhabit, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison IQVIA Holdings, Inc. has a beta of 1.364, suggesting its more volatile than the S&P 500 by 36.392%.

  • Which is a Better Dividend Stock EHAB or IQV?

    Enhabit, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enhabit, Inc. pays -- of its earnings as a dividend. IQVIA Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios EHAB or IQV?

    Enhabit, Inc. quarterly revenues are $263.6M, which are smaller than IQVIA Holdings, Inc. quarterly revenues of $4.1B. Enhabit, Inc.'s net income of $11.6M is lower than IQVIA Holdings, Inc.'s net income of $332M. Notably, Enhabit, Inc.'s price-to-earnings ratio is -- while IQVIA Holdings, Inc.'s PE ratio is 30.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enhabit, Inc. is 0.45x versus 2.49x for IQVIA Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    EHAB
    Enhabit, Inc.
    0.45x -- $263.6M $11.6M
    IQV
    IQVIA Holdings, Inc.
    2.49x 30.95x $4.1B $332M
  • Which has Higher Returns EHAB or JYNT?

    The Joint Corp. (United States) has a net margin of 4.4% compared to Enhabit, Inc.'s net margin of 2.17%. Enhabit, Inc.'s return on equity of -1.74% beat The Joint Corp. (United States)'s return on equity of -1.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    EHAB
    Enhabit, Inc.
    46.4% $0.22 $1.1B
    JYNT
    The Joint Corp. (United States)
    76.77% $0.06 $24.8M
  • What do Analysts Say About EHAB or JYNT?

    Enhabit, Inc. has a consensus price target of $9.75, signalling upside risk potential of 5.75%. On the other hand The Joint Corp. (United States) has an analysts' consensus of $10.67 which suggests that it could grow by 22.32%. Given that The Joint Corp. (United States) has higher upside potential than Enhabit, Inc., analysts believe The Joint Corp. (United States) is more attractive than Enhabit, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    EHAB
    Enhabit, Inc.
    1 4 0
    JYNT
    The Joint Corp. (United States)
    1 3 0
  • Is EHAB or JYNT More Risky?

    Enhabit, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Joint Corp. (United States) has a beta of 1.291, suggesting its more volatile than the S&P 500 by 29.096%.

  • Which is a Better Dividend Stock EHAB or JYNT?

    Enhabit, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Joint Corp. (United States) offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enhabit, Inc. pays -- of its earnings as a dividend. The Joint Corp. (United States) pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios EHAB or JYNT?

    Enhabit, Inc. quarterly revenues are $263.6M, which are larger than The Joint Corp. (United States) quarterly revenues of $13.4M. Enhabit, Inc.'s net income of $11.6M is higher than The Joint Corp. (United States)'s net income of $290.4K. Notably, Enhabit, Inc.'s price-to-earnings ratio is -- while The Joint Corp. (United States)'s PE ratio is 75.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enhabit, Inc. is 0.45x versus 2.44x for The Joint Corp. (United States). Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    EHAB
    Enhabit, Inc.
    0.45x -- $263.6M $11.6M
    JYNT
    The Joint Corp. (United States)
    2.44x 75.63x $13.4M $290.4K
  • Which has Higher Returns EHAB or WORX?

    SCWorx Corp. has a net margin of 4.4% compared to Enhabit, Inc.'s net margin of -185.96%. Enhabit, Inc.'s return on equity of -1.74% beat SCWorx Corp.'s return on equity of -74.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    EHAB
    Enhabit, Inc.
    46.4% $0.22 $1.1B
    WORX
    SCWorx Corp.
    16.88% -$0.15 $6M
  • What do Analysts Say About EHAB or WORX?

    Enhabit, Inc. has a consensus price target of $9.75, signalling upside risk potential of 5.75%. On the other hand SCWorx Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Enhabit, Inc. has higher upside potential than SCWorx Corp., analysts believe Enhabit, Inc. is more attractive than SCWorx Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    EHAB
    Enhabit, Inc.
    1 4 0
    WORX
    SCWorx Corp.
    0 0 0
  • Is EHAB or WORX More Risky?

    Enhabit, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SCWorx Corp. has a beta of 2.027, suggesting its more volatile than the S&P 500 by 102.683%.

  • Which is a Better Dividend Stock EHAB or WORX?

    Enhabit, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enhabit, Inc. pays -- of its earnings as a dividend. SCWorx Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios EHAB or WORX?

    Enhabit, Inc. quarterly revenues are $263.6M, which are larger than SCWorx Corp. quarterly revenues of $705.8K. Enhabit, Inc.'s net income of $11.6M is higher than SCWorx Corp.'s net income of -$1.3M. Notably, Enhabit, Inc.'s price-to-earnings ratio is -- while SCWorx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enhabit, Inc. is 0.45x versus 0.27x for SCWorx Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    EHAB
    Enhabit, Inc.
    0.45x -- $263.6M $11.6M
    WORX
    SCWorx Corp.
    0.27x -- $705.8K -$1.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Sell
50
NUTX alert for Jan 1

Nutex Health, Inc. [NUTX] is down 9.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock